SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-22-004725
Filing Date
2022-04-11
Accepted
2022-04-11 16:36:06
Documents
12
Period of Report
2022-04-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_040722.htm   iXBRL 8-K 34908
  Complete submission text file 0001387131-22-004725.txt   208877

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE admp-20220407.xsd EX-101.SCH 3072
3 XBRL LABEL FILE admp-20220407_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE admp-20220407_pre.xml EX-101.PRE 22621
6 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_040722_htm.xml XML 3591
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 22820046
SIC: 2834 Pharmaceutical Preparations